Logistics solutions for the pharma and healthcare industry are among the most important growth drivers for Kuehne + Nagel’s European overland business. With the extension of the European overland cross dock platform in Luxembourg and the integration of telematics data of key providers Kuehne + Nagel strengthens its position in the European market for pharma solutions.
Uwe Hött, Senior Vice President Overland Europe at Kuehne + Nagel, said: “Industry specific services for customers from the pharma & healthcare industry mark a key factor of Kuehne + Nagel’s success story in overland business. The investment into our Luxembourg pharma platform and the integration of telematics data of qualified key transport partners contribute significantly towards our overall strategy for the pharma industry with a special focus on temperature controlled transportation for both FTL and LTL. The extension of the Contern, Luxembourg, facility will enhance providing industry leading services with increased capacity for our customers. “
The platform in Contern is part of Kuehne + Nagel’s KN PharmaChain. KN PharmaChain is a multi-modal logistics solution for temperature controlled door-to-door transportation which allows accurate traceability of the deliveries and intensive, proactive risk management.
Luxembourg also established fully GDP secured end-to-end trade lanes for pharma and healthcare shipments with both Hong Kong and Shanghai. A memorandum of understanding was signed between Luxembourg airport on the one side and Hong Kong Air Cargo Terminals and Eastern Air Logistics in Shanghai, respectively, on the other side. The goal is to maintain GDP standards for all healthcare-related shipments that travel between Luxembourg airport and Hong Kong as well as Shanghai.